Cover
Cover - shares | 3 Months Ended | |
Mar. 31, 2023 | May 05, 2023 | |
Entity Information [Line Items] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Mar. 31, 2023 | |
Document Transition Report | false | |
Entity File Number | 001-04321 | |
Entity Registrant Name | NUSCALE POWER CORPORATION | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 98-1588588 | |
Entity Address, Address Line One | 6650 SW Redwood Ln Suite 210 | |
Entity Address, City or Town | Portland | |
Entity Address, State or Province | OR | |
Entity Address, Postal Zip Code | 97224 | |
City Area Code | 971) | |
Local Phone Number | 371-1592 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | false | |
Entity Shell Company | false | |
Entity Central Index Key | 0001822966 | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2023 | |
Amendment Flag | false | |
Document Fiscal Period Focus | Q1 | |
Class A | ||
Entity Information [Line Items] | ||
Title of 12(b) Security | Class A common stock, $0.0001 par value per share | |
Trading Symbol | SMR | |
Security Exchange Name | NYSE | |
Entity Common Stock, Shares Outstanding | 70,441,214 | |
Class B | ||
Entity Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 157,090,820 | |
Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share | ||
Entity Information [Line Items] | ||
Title of 12(b) Security | Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share | |
Trading Symbol | SMR.WS | |
Security Exchange Name | NYSE |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheet - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Current assets | ||
Cash and cash equivalents | $ 218,164 | $ 217,685 |
Short-term investments | 0 | 50,000 |
Prepaid expenses | 7,304 | 5,531 |
Accounts and other receivables | 20,992 | 11,199 |
Total current assets | 246,460 | 284,415 |
Property, plant and equipment, net | 4,506 | 4,770 |
In-process research and development | 16,900 | 16,900 |
Intangible assets, net | 1,015 | 1,059 |
Goodwill | 8,255 | 8,255 |
Restricted cash | 34,182 | 26,532 |
Other assets | 5,054 | 6,704 |
Long-term contract work in process | 16,018 | 0 |
Total assets | 332,390 | 348,635 |
Current liabilities | ||
Accounts payable and accrued expenses | 43,738 | 27,951 |
Accrued compensation | 6,442 | 9,038 |
Other accrued liabilities | 1,511 | 1,568 |
Total current liabilities | 51,691 | 38,557 |
Warrant liabilities | 30,457 | 29,349 |
Noncurrent liabilities | 2,433 | 2,786 |
Deferred revenue | 1,078 | 856 |
Total liabilities | 85,659 | 71,548 |
Stockholders’ Equity | ||
Additional paid-in capital | 302,487 | 296,748 |
Accumulated deficit | (193,054) | (182,092) |
Total Stockholders’ Equity Excluding Noncontrolling Interests | 109,456 | 114,679 |
Noncontrolling interests | 137,275 | 162,408 |
Total Stockholders' Equity | 246,731 | 277,087 |
Total Liabilities and Stockholders' Equity | 332,390 | 348,635 |
Class A | ||
Stockholders’ Equity | ||
Common stock, value | 7 | 7 |
Class B | ||
Stockholders’ Equity | ||
Common stock, value | $ 16 | $ 16 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheet (Parenthetical) | Mar. 31, 2023 $ / shares shares |
Class A | |
Common stock, par value (in usd per share) | $ / shares | $ 0.0001 |
Common stock, shares authorized (in shares) | 332,000,000 |
Common stock, shares outstanding (in shares) | 70,061,055 |
Class B | |
Common stock, par value (in usd per share) | $ / shares | $ 0.0001 |
Common stock, shares authorized (in shares) | 179,000,000 |
Common stock, shares outstanding (in shares) | 157,090,820 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Income Statement [Abstract] | ||
Revenue | $ 5,505 | $ 2,445 |
Cost of sales | (3,416) | (1,205) |
Gross margin | 2,089 | 1,240 |
Research and development expenses | 25,715 | 24,380 |
General and administrative expenses | 14,695 | 10,520 |
Other expenses | 17,151 | 10,188 |
Loss from operations | (55,472) | (43,848) |
Sponsored cost share | 17,873 | 20,577 |
Decrease (increase) in fair value of warrant liabilities | (1,108) | 0 |
Interest income (expense) | 3,097 | (102) |
Loss before income taxes | (35,610) | (23,373) |
Provision (benefit) for income taxes | 0 | 0 |
Net loss | (35,610) | (23,373) |
Net loss attributable to legacy NuScale LLC holders prior to Transaction | 0 | $ (23,373) |
Net loss attributable to noncontrolling interests | (24,648) | |
Net Loss Attributable to Class A Common Stockholders | $ (10,962) | |
Loss Per Share of Class A Common Stock: | ||
Basic (in usd per share) | $ (0.16) | $ 0 |
Diluted (in usd per share) | $ (0.16) | $ 0 |
Weighted-Average Shares of Class A Common Stock Outstanding: | ||
Basic (in shares) | 69,684,268 | 0 |
Diluted (in shares) | 69,684,268 | 0 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Changes in Stockholders’ Equity - USD ($) $ in Thousands | Total | Class A | Class B | Convertible Preferred Units | Common Units | Common Stock Class A | Common Stock Class B | Additional Paid-in Capital | Accumulated Deficit | Noncontrolling Interests |
Beginning balance (shares) at Dec. 31, 2021 | 6,000,000 | |||||||||
Beginning balance at Dec. 31, 2021 | $ 2,140 | |||||||||
Ending balance (shares) at Mar. 31, 2022 | 6,000,000 | |||||||||
Ending balance at Mar. 31, 2022 | $ 2,140 | |||||||||
Beginning balance (in shares) at Dec. 31, 2021 | 633,261,000 | |||||||||
Beginning balance at Dec. 31, 2021 | 66,258 | $ 819,694 | $ 28,184 | $ (781,620) | ||||||
Beginning balance (in shares) at Dec. 31, 2021 | 9,074,000 | |||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||
Equity-based compensation expense | 1,021 | $ 1,021 | ||||||||
Exercise of common unit options (in shares) | 2,928,000 | |||||||||
Exercise of common unit options | 470 | $ 470 | ||||||||
Conversion of equity award to liability award | (50) | $ (50) | ||||||||
Repurchase of common units (in shares) | (343,000) | |||||||||
Repurchase of common units | (563) | $ (563) | ||||||||
Issuance of treasury units/stock (in shares) | 12,000 | |||||||||
Issuance of treasury units/stock | 20 | $ 20 | ||||||||
Net loss | (23,373) | (23,373) | ||||||||
Ending balance (in shares) at Mar. 31, 2022 | 633,261,000 | |||||||||
Ending balance at Mar. 31, 2022 | 43,783 | $ 819,694 | $ 29,082 | (804,993) | ||||||
Ending balance (in shares) at Mar. 31, 2022 | 11,671,000 | |||||||||
Beginning balance (in shares) at Dec. 31, 2022 | 69,353,000 | 157,091,000 | ||||||||
Beginning balance at Dec. 31, 2022 | 277,087 | $ 7 | $ 16 | $ 296,748 | (182,092) | $ 162,408 | ||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||
Equity-based compensation expense | 3,637 | 3,637 | ||||||||
Exercise of common share options and warrants and vested RSUs (in shares) | 708,000 | |||||||||
Exercise of common share options and warrants and vested RSUs | $ 1,617 | 1,617 | ||||||||
Exercise of common unit options (in shares) | 693,734 | |||||||||
Rebalancing of ownership percentage for conversion of combined interest into Class A shares | $ 0 | 485 | (485) | |||||||
Net loss | (35,610) | (10,962) | (24,648) | |||||||
Ending balance (in shares) at Mar. 31, 2023 | 70,061,055 | 157,090,820 | 70,061,000 | 157,091,000 | ||||||
Ending balance at Mar. 31, 2023 | $ 246,731 | $ 7 | $ 16 | $ 302,487 | $ (193,054) | $ 137,275 |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
OPERATING CASH FLOW | ||
Net loss | $ (35,610) | $ (23,373) |
Adjustments to reconcile net loss to operating cash flow: | ||
Depreciation | 615 | 577 |
Amortization of intangibles | 44 | 44 |
Equity-based compensation expense | 3,637 | 1,021 |
Change in the fair value of warrant liabilities | 1,108 | 0 |
Net noncash change in right of use assets and lease liabilities | (345) | 406 |
Changes in assets and liabilities: | ||
Prepaid expenses and other assets | (99) | (1,371) |
Accounts receivable | (9,793) | (2,716) |
Accounts payable and accrued expenses | (170) | (646) |
Lease liability | (150) | (452) |
Deferred DOE cost share | 0 | (105) |
Deferred revenue | 222 | (773) |
Accrued compensation | (2,596) | (5,763) |
Net cash used in operating activities | (43,137) | (33,151) |
INVESTING CASH FLOW | ||
Sale of short-term investments | 50,000 | 0 |
Purchases of property, plant and equipment | (351) | (1,187) |
Net cash provided by (used in) investing activities | 49,649 | (1,187) |
FINANCING CASH FLOW | ||
Proceeds from exercise of common unit options | 0 | 470 |
Repurchase of common units | 0 | (563) |
Issuance of treasury units | 0 | 20 |
Proceeds from exercise of warrants and common share options | 1,617 | 0 |
Net cash provided by (used in) financing activities | 1,617 | (73) |
Net increase in cash, cash equivalents and restricted cash | 8,129 | (34,411) |
Cash, cash equivalents and restricted cash | ||
Beginning of period | 244,217 | 77,094 |
End of period | 252,346 | 42,683 |
Summary of noncash investing and financing activities: | ||
Conversion of equity options to liability award | 0 | 1,540 |
Long-term contract work in process in accounts payable | $ 16,018 | $ 0 |
Nature of Business
Nature of Business | 3 Months Ended |
Mar. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Nature of Business | Nature of Business Organization and Operations NuScale Power Corporation (“NuScale Corp”, the “Company”, “us”, “we” or “our”) is commercializing a modular, scalable 77 MWe (gross) light water reactor nuclear power plant using exclusive rights to a nuclear power plant design obtained from Oregon State University. The Company is majority owned by Fluor. Merger with Spring Valley In December 2021, NuScale LLC entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Spring Valley Acquisition Corp. (“Spring Valley”) and Spring Valley Merger Sub, LLC (“Merger Sub”), a wholly owned subsidiary of Spring Valley. Pursuant to the Merger Agreement, Merger Sub merged with and into NuScale LLC (the “Merger”), with NuScale LLC surviving the Merger (the “Surviving Company”), Spring Valley being renamed NuScale Corp, and NuScale LLC continuing to be held as a wholly controlled subsidiary of NuScale Power Corporation in an “Up-C” structure. On May 2, 2022, the Merger Agreement and Merger (collectively the “Transaction”) was completed. The Transaction is shown as a reverse recapitalization under GAAP. Spring Valley is the acquired company, with NuScale LLC treated as the acquirer. This determination reflects Legacy NuScale Equityholders holding a majority of the voting power of NuScale Corp, NuScale LLC’s pre-merger operations being the majority post-merger operations of NuScale Corp, and NuScale LLC’s management team retaining similar roles at NuScale Corp. Accordingly, although Spring Valley is the legal parent company, GAAP dictates that the financial statements of NuScale Corp will represent a continuation of NuScale LLC’s operations, with the Transaction being treated as though NuScale LLC issued ownership interests for Spring Valley, accompanied by a recapitalization. The net assets of NuScale LLC are stated at historical cost, with no incremental goodwill or other intangible assets recorded for the effects of the Transaction with Spring Valley. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies Basis of Presentation The Company’s unaudited condensed consolidated financial statements and related notes do not include notes and certain financial information normally presented annually under GAAP, and therefore should be read in conjunction with our 2022 Annual Report on Form 10-K. Accounting measures at interim dates inherently involve greater reliance on estimates than at year-end. Although such estimates are based on management’s most recent assessment of the underlying facts and circumstances utilizing the most current information available, our reported results of operations may not necessarily be indicative of results that we expect for the full year. These financial statements are unaudited. In management’s opinion, they contain all adjustments of a normal recurring nature which are necessary to present fairly our financial position and our operating results as of and for the interim periods presented. Principles of Consolidation As part of the Transaction, NuScale Corp has been determined to be the primary beneficiary of NuScale Power, LLC (“NuScale LLC”), a variable interest entity (“VIE”). As the sole managing member of NuScale LLC, NuScale Corp has both the power to direct the activities, and direct ownership to share in the revenues and expenses of NuScale LLC. As such, all the activity of NuScale LLC has been consolidated in the accompanying condensed consolidated financial statements. All assets and liabilities included in the balance sheet are that of NuScale LLC, other than the NuScale Corp Warrants and certain prepaid insurance. All significant intercompany transactions have been eliminated upon consolidation. Changes in Presentation Prior year amounts totaling $115, previously identified as Other cost share (interest expense) but currently described as Interest income (expense), have been reclassified to Sponsored other cost share to conform to the current year presentation on the accompanying condensed consolidated statements of operations. Cash, Cash Equivalents and Restricted Cash Cash equivalents represent short-term, highly liquid investments, which are readily convertible to cash and have maturities of three months or less at time of purchase. Cash equivalents with an initial maturity of between three and twelve months at time of purchase are presented as short-term investments on the accompanying condensed consolidated balance sheet. Cash equivalents and short-term investments consist of certificates of deposit. These certificates of deposit are classified as held-to-maturity, and the estimated fair value of the investment approximates its amortized cost. Cash in the amount of $34,182 is restricted as collateral for the letter of credit associated with the Development Cost Reimbursement Agreement (“DCRA”) at March 31, 2023 (See Note 13). The DCRA spans multiple years requiring the amount to be classified as a noncurrent asset, included in Restricted cash in the accompanying condensed consolidated balance sheet. The Restricted cash balance plus Cash and cash equivalents on the accompanying condensed consolidated balance sheet equals cash, cash equivalents and restricted cash, as reflected in the accompanying condensed consolidated statements of cash flows. Warrant Liability The Company accounts for the Warrants in accordance with the guidance contained in Accounting Standards Codification (“ASC”) 815, “Derivatives and Hedging”, under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjusts the warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s condensed consolidated statements of operations. The fair value of the Public and Private Placement Warrants has been estimated using the Public Warrants’ quoted market price. See note 4 for further discussion of the terms of the Warrants and note 5 for further discussion of the methodology used to determine the value of the Warrants. Sponsored cost share As we continue to advance our commercialization activities, we have begun to enter into cost share agreements with various entities, including both governmental and private, whereby NuScale is reimbursed for specific R&D performed. Currently, these entities include the DOE, United State Trade and Development Agency (“USTDA”) and CFPP, among others. Beginning in 2014, the U.S. DOE has provided critical funding to NuScale through a series of cooperative agreements which support ongoing commercialization activities. During the three months ended March 31, 2023 and 2022, DOE cost share totaled $12,354 and $20,462, respectively. Beginning in 2021, NuScale partnered with the USTDA to develop SMRs in foreign markets. Under the USTDA’s technical assistance grant program we receive cost share commitments to support licensing work in these foreign markets. During the three months ended March 31, 2023 and 2022, USTDA cost share totaled $2,415 and $115, respectively. Finally, we receive cost share from CFPP, LLC as a subrecipient under a contract between the DOE and UAMPS for R&D performed with the goal of developing our first SMR. Under this agreement we received cost share of $2,939 during the three months ended March 31, 2023, with no cost share during the same period in the prior year. Income Taxes NuScale Corp accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that the deferred tax assets will be realized. Deferred tax assets and liabilities are calculated by applying existing tax laws and the rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the year of the enacted rate change. The Company accounts for uncertainty in income taxes using a recognition and measurement threshold for tax positions taken or expected to be taken in a tax return, which are subject to examination by federal and state taxing authorities. The tax benefit from an uncertain tax position is recognized when it is more likely than not that the position will be sustained upon examination by taxing authorities based on technical merits of the position. The amount of the tax benefit recognized is the largest amount of the benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. The effective tax rate and the tax basis of assets and liabilities reflect management’s estimates of the ultimate outcome of various tax uncertainties. Once identified, the Company will recognize penalties and interest related to uncertain tax positions within the provision (benefit) for income taxes line in the accompanying consolidated statements of operations. NuScale LLC is a limited liability company treated as a partnership for U.S. federal income tax purposes that is not subject to U.S. federal income tax. As such, its net taxable income or loss and any related tax credits are allocated to its members. |
Noncontrolling Interests and Lo
Noncontrolling Interests and Loss Per Share | 3 Months Ended |
Mar. 31, 2023 | |
Noncontrolling Interest And Earnings Per Share [Abstract] | |
Noncontrolling Interests and Loss Per Share | Noncontrolling Interests and Loss Per Share Noncontrolling Interests Following the Transaction, holders of Class A common stock own direct controlling interest in the results of the combined entity, while the Legacy NuScale Equityholders own an economic interest in NuScale LLC, shown as noncontrolling interests (“NCI”) in equity in NuScale Corp’s condensed consolidated financial statements. The indirect economic interests are held by Legacy NuScale Equityholders in the form of NuScale LLC Class B Units. The following table summarizes the economic interests of NuScale Corp between the holders of Class A common stock and indirect economic interests held by NuScale LLC Class B unitholders as of and for the three months ended March 31, 2023: Noncontrolling Interest As of and for the three months ended March 31, 2023 NuScale Corp Class A common stock Beginning of period 69,353,019 Conversion of combined interests into Class A common stock — Exercise of options and warrants and vested RSUs 708,036 End of period 70,061,055 NuScale LLC Class B Units (NCI) Beginning of period 157,090,820 Conversion of combined interests into Class A common stock — End of period 157,090,820 Total Beginning of period 226,443,839 Conversion of combined interests into Class A common stock — Exercise of options and warrants and vested RSUs 708,036 End of period 227,151,875 Ownership Percentage NuScale Corp Class A common stock Beginning of period 30.6 % End of period 30.8 % NuScale LLC Class B Units (NCI) Beginning of period 69.4 % End of period 69.2 % The NCI may decrease according to the number of shares of Class B common stock and NuScale LLC Class B units that are exchanged for shares of Class A common stock or, in certain circumstances including at the election of NuScale Corp, cash in an amount equal to the fair value of Class A common stock received in a contemporaneous equity issuance. After each exchange, NuScale LLC equity attributable to NuScale Corp is rebalanced to reflect the change in ownership percentage, which is calculated above based on Class B units and Class A shares, as a percentage of Combined interests. Loss Per Share Prior to the Transaction, the membership structure of NuScale LLC included units that had profit interests. The Company analyzed the calculation of net loss per unit for periods prior to the Transaction and determined that it resulted in values that would not be meaningful to the readers of these financial statements. Therefore, net loss per unit information has not been presented for periods prior to May 2, 2022. Basic loss per share is based on the average number of shares of Class A common stock outstanding during the period. Diluted loss per share is based on the average number of shares of Class A common stock used for the basic earnings per share calculation, adjusted for the dilutive effect of RSUs, Stock Options and Warrants using the “treasury stock” method and for all other interests that convert into potential shares of Class A common stock, if any, using the “if converted” method. Net loss attributable to Class A common stockholders for diluted loss per share is adjusted for the Company’s share of NuScale LLC’s net loss, net of NuScale Corp taxes, after giving effect to all other interests that convert into potential shares of Class A common stock, to the extent it is dilutive. In addition, net loss attributable to Class A common stockholders for diluted loss per share is adjusted for the after-tax impact of changes to the fair value of derivative liabilities, to the extent the Company’s Warrants are dilutive. The following table sets forth the computation of basic and diluted net loss per share of Class A common stock and represents the three months ended March 31, 2023, the period where the Company had Class A and Class B common stock outstanding. Class B common stock represents a right to cast one vote per share at the NuScale Corp level, and carry no economic rights, including rights to dividends or distributions upon liquidation, and as a result, is not considered a participating security for basic and diluted loss per share. As such, basic and diluted loss per share of Class B common stock has not been presented. Three Months Ended March 31, 2023 Net loss attributable to Class A common stockholders $ (10,962) Weighted-average shares for basic and diluted loss per share 69,684,268 Basic and Diluted loss per share of Class A common stock $ (0.16) Anti-dilutive securities excluded from shares outstanding: Class B common shares 157,090,820 Stock options 11,447,940 Warrants 18,458,701 Time-based RSUs 3,910,760 Total 190,908,221 |
Warrant Liabilities
Warrant Liabilities | 3 Months Ended |
Mar. 31, 2023 | |
Warrants and Rights Note Disclosure [Abstract] | |
Warrant Liabilities | Warrant Liabilities As of March 31, 2023, the Company had 9,558,701 Public Warrants and 8,900,000 Private Placement Warrants outstanding. Warrants may only be exercised for a whole number of shares. No fractional shares will be issued upon exercise of the Warrants. The Warrants are currently exercisable and will expire five years from the date of the Transaction or earlier upon redemption or liquidation. Redemption of Warrants when the price per share of Class A common stock equals or exceeds $18.00 . The Company may redeem the outstanding Warrants (except as described with respect to the Private Placement Warrants): • in whole and not in part; • at a price of $0.01 per Warrant; • upon a minimum of 30 days’ prior written notice of redemption to each Warrant holder; and • if the closing price of the Class A common stock equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending three trading days before the Company sends the notice of redemption to the Warrant holders. If and when the Warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. Redemption of Warrants when the price per share of Class A common stock equals or exceeds $10.00 . The Company may redeem the outstanding warrants: • in whole and not in part; • at $0.10 per Warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their Warrants on a cashless basis prior to redemption and receive that number of shares determined based on the redemption date and the fair market value of the Class A common stock; • if, and only if, the closing price of the Class A common stock equals or exceeds $10.00 per public share (as adjusted) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption to the Warrant holders; and • if the closing price of the Class A common stock for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the Warrant holders is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding Public Warrants. If the Company calls the Public Warrants for redemption, as described above, the exercise price and number of ordinary shares issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a share dividend, extraordinary dividend or recapitalization, reorganization, merger, or consolidation. Beginning on the 30th day following the Transaction, the Private Placement Warrants became almost identical to the Public Warrants sold in the Spring Valley Initial Public Offering. Additionally, the Private Placement Warrants are exercisable on a cashless basis and are non-redeemable, except as described above, so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. |
Fair Value Measurement
Fair Value Measurement | 3 Months Ended |
Mar. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurement | Fair Value Measurement The Company measures certain financial assets and liabilities at fair value. Fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the Company uses a three-level hierarchy, which prioritizes fair value measurements based on the types of inputs used for the various valuation techniques (market approach, income approach and cost approach). The levels of hierarchy are described below: Level 1 Quoted prices in active markets for identical instruments; Level 2 Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and Level 3 Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability. Financial assets and liabilities are classified in their entirety based on the most stringent level of input that is significant to the fair value measurement. The carrying amount of certain financial instruments, including deposits, accounts payable, accrued expenses and convertible notes payable approximates fair value due to their short maturities. Our Warrants are accounted for as liabilities pursuant to ASC 815-40 and are measured at fair value as of each reporting period. Changes in fair value of the Warrants are recorded in the consolidated statements of operations each period. Due to the similarity of the features of the Public and Private Warrants, management has concluded that the price of the Public Warrants would be used in the valuation of the Private Placement Warrants. However, since the two types of Warrants are not identical and the Private Warrants are not actively traded, we have classified the Private Placement Warrants as Level 2, while the Public Warrants are classified as Level 1. The following table represents the Company’s financial liabilities measured at fair value on a recurring basis as of March 31, 2023: (in thousands) Level 1 Level 2 Level 3 Total Warrant Liabilities: Public Warrants $ 15,772 $ — $ — $ 15,772 Private Placement Warrants — 14,685 — 14,685 Total Warrant Liabilities as of March 31, 2023 $ 15,772 $ 14,685 $ — $ 30,457 |
Accounts and Other Receivables
Accounts and Other Receivables | 3 Months Ended |
Mar. 31, 2023 | |
Receivables [Abstract] | |
Accounts and Other Receivables | Accounts and Other Receivables Accounts and other receivables include reimbursement requests outstanding from the DOE awards, interest receivable and commercial accounts receivable associated with other federal projects. The DOE reimbursement requests are recognized as eligible costs are incurred. Reimbursement under the awards is recognized as award funds are obligated, and are included in Department of Energy Cost Share in the consolidated statement of operations. Interest receivable of $329 was outstanding at March 31, 2023. The majority of our receivables are either due from the U.S. federal government or have to do with a federal project. For these reasons, all receivables are deemed to be fully collectible and no allowance has been recorded. |
Property, Plant and Equipment
Property, Plant and Equipment | 3 Months Ended |
Mar. 31, 2023 | |
Property, Plant and Equipment [Abstract] | |
Property, Plant and Equipment | Property, Plant and Equipment Property, plant and equipment consisted of the following: March 31, December 31, (in thousands) 2023 2022 Furniture and fixtures $ 145 $ 173 Office and computer equipment 7,475 7,393 Software 13,918 13,864 Test equipment 347 347 Leasehold improvements 2,281 2,312 24,166 24,089 Less: Accumulated depreciation (19,947) (19,431) Add: Assets under development 287 112 Net property, plant and equipment $ 4,506 $ 4,770 |
Long-Term Contract Work In Proc
Long-Term Contract Work In Process | 3 Months Ended |
Mar. 31, 2023 | |
Debt Disclosure [Abstract] | |
Long-Term Contract Work In Process | Long-Term Contract Work In Process During the first quarter, we entered into a long lead material contract with Carbon Free Power Project, LLC (“CFPP LLC”). Related to this contract, the Company has subcontracted for the purchase of certain long-lead materials in the amount of $54,600, that will be used in fabricating of the NPMs as part of the overall contract with CFPP LLC. This first phase of the project will be completed for CFPP, LLC near the end of 2024. The subcontractor is manufacturing the long-lead materials on behalf of NuScale, and we are considered the principal, rather than agent, under ASC 606, Revenue from Contracts with Customers . The contract contains one performance obligation that will be satisfied once the materials are verified as received at the fabricator’s facility. As of March 31, 2023, $14,200 has been capitalized in the Long-term contract work in process line item on our consolidated balance sheet related to this contract. |
Employee Benefits
Employee Benefits | 3 Months Ended |
Mar. 31, 2023 | |
Retirement Benefits [Abstract] | |
Employee Benefits | Employee BenefitsNuScale sponsors a defined contribution 401(k) Plan with Company contributions to be made at the sole discretion of management. Under the provisions of the 401(k) Plan, the Company matches the employees’ contributions for the first 3% of compensation and matches 50% of the employees’ contributions for the next 2% of compensation. The expense recorded for the 401(k) Plan was $751 and $672 for the three months ended March 31, 2023 and 2022, respectively |
Income Taxes
Income Taxes | 3 Months Ended |
Mar. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes NuScale LLC was historically, and remains a partnership for U.S. federal income tax purposes with each partner being separately taxed on its share of taxable income or loss. NuScale Corp is subject to U.S. federal income taxes, in addition to state and local income taxes, with respect to its distributive share of any net taxable income or loss and any related tax credits of NuScale LLC. The effective tax rate was 0% for the three months ended March 31, 2023. The effective income tax rate for the three months ended March 31, 2023 differed significantly from the statutory rates, primarily due to the losses allocated to NCI and the recognition of a valuation allowance as a result of the Company’s new tax structure following the Transaction. There was no income tax expense recorded during the three months ended March 31, 2023. The Company has assessed the realizability of the net deferred tax assets and in that analysis has considered the relevant positive and negative evidence available to determine whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The Company has recorded a full valuation allowance against the deferred tax assets at NuScale Corp as of March 31, 2023, which will be maintained until there is sufficient evidence to support the reversal of all or some portion of these allowances. The Company’s income tax filings will be subject to audit by various taxing jurisdictions. The Company will monitor the status of U.S. federal, state and local income tax returns that may be subject to audit in future periods. No U.S. federal, state and local income tax returns are currently under examination by the respective taxing authorities. In August 2022, the Inflation Reduction Act, or IRA, was enacted which includes the following key summary provisions: (i) a 15% Corporate Alternative Minimum Tax, or CAMT, that allows an offset of up to 75% with existing tax credit carryforwards, (ii) excise tax applicable to certain stock repurchases including ordinary buy backs and open market repurchases, (iii) extension and expansion of clean energy credits and incentives, and (iv) indefinite carryover of the CAMT. This legislation also provides transferability opportunities for certain newly generated credits as well as a direct pay option. For the three months ended March 31, 2023, the enactment of the IRA did not result in any material adjustment to our income tax provision. |
Equity-Based Compensation
Equity-Based Compensation | 3 Months Ended |
Mar. 31, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Equity-Based Compensation | Equity-Based Compensation The total compensation expense recognized for common share options and time-based RSU awards during the three months ended March 31, 2023 and 2022 was $3,637 and $1,021, respectively. This includes G&A expense of $1,493 and other expense of $2,144 for the three months ended March 31, 2023 and $444 of G&A expense and $577 in other expense for the three months ended March 31, 2022. Effective January 1, 2023, the share pool was automatically increased by 8,972,128, which is the number of shares of Class A common stock equal to four percent (4%) of the aggregate number of shares of Class A common stock and Class B common stock outstanding on December 31, 2022, excluding any such outstanding shares of Class A common stock that were granted under the 2022 long-term incentive plan and remain unvested and subject to forfeiture as of December 31, 2022. Stock Options The following table summarizes the activity of the Company’s common stock options as of and for the three months ended March 31, 2023: Share Options Number of Weighted Average Outstanding at December 31, 2022 12,224,783 $ 4.09 Granted — — Exercised (693,734) 2.30 Forfeited (80,674) 6.43 Expired (2,435) 5.54 Outstanding at March 31, 2023 11,447,940 4.18 Exercisable at March 31, 2023 10,379,278 3.90 The Company measures the fair value of each share option grant at the date of grant using a Black-Scholes option pricing model. Time-based RSUs During the three months ended March 31, 2023, the Board approved 1,835,016 employee RSU awards that vest one-third annually starting in February 2024 for a period of three years. The following table summarizes the activity of the Company’s time-based RSUs as of and for the three months ended March 31, 2023: Number of RSUs Weighted Average Time-based RSUs Grant-Date Fair Value Outstanding at December 31, 2022 2,140,651 $ 10.71 Granted 1,835,016 10.35 Vested (14,300) 10.20 Forfeited/Expired (50,607) 11.12 Outstanding at March 31, 2023 3,910,760 $ 10.54 Common Unit Appreciation Rights In April 2013, the Company granted its Chief Executive Officer 1,000,000 NuScale LLC common unit appreciation rights (“UARs”). The UARs vested one-third each year on the anniversary of the grant date. Upon exercise of a UAR, the holder would receive common units equal to the excess of the fair value of the common units over the strike price of $0.11 at the grant date multiplied by the number of rights exercised and divided by the fair value of the common unit upon exercise. In February 2022, the NuScale LLC Board of Managers approved a $1,540 cash payment (paid during the three months ended June 30, 2022) in lieu of equity issuance related to the UARs, which triggered recognition of $1,490 of equity-based compensation expense, included in G&A, during the three months ended March 31, 2022. |
Related Party Transactions
Related Party Transactions | 3 Months Ended |
Mar. 31, 2023 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | Related Party TransactionsFrom time to time, the Company enters into strategic agreements with Fluor, whereby Fluor or NuScale perform services for one another. For the three months ended March 31, 2023 and 2022, NuScale incurred expenses of $8,726 and $3,601, respectively. As of March 31, 2023 and December 31, 2022, NuScale owes Fluor, as accounts payable and accrued expenses on the condensed consolidated balance sheet, amounts totaling $9,162 and $7,694, respectively. For the three months ended March 31, 2023 and 2022, NuScale earned revenue of $4,014 and $1,561, respectively. As of March 31, 2023 and December 31, 2022, Fluor owes NuScale $6,101 and $1,508, respectively, amounts which are included in accounts and other receivables on the condensed consolidated balance sheet. For the three months ended March 31, 2023 Fluor accounted for 72.9% of total revenue. |
Commitment and Contingencies
Commitment and Contingencies | 3 Months Ended |
Mar. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies In the regular course of business, the Company is involved in various legal proceedings and claims incidental to the normal course of business. Additionally, the Company is involved in various legal proceedings and claims relating to the Transaction with Spring Valley. These legal proceedings relate to the level of disclosure of matters prior to the Transaction, which the Company believes were timely addressed well before the Transaction. The Company does not believe that any of the claims are material to the Company. Management does not believe that resolution of any of these matters will materially affect the Company’s financial position or results of operations. On September 19, 2022, thirteen purported members of NuScale LLC filed suit in the U.S. District Court for the District of Oregon against NuScale LLC, Fluor Enterprises, Japan NuScale Innovation, Inc., and Sargent & Lundy Holdings, LLC. The plaintiffs purport to represent a class of individuals who held common units or options to purchase common units in NuScale LLC and seek declaratory relief and damages based on breach of contract and other common law claims. The claims are based on amendments to the operating agreement of NuScale LLC in connection with the Merger between NuScale LLC and Spring Valley Acquisition Corp. Plaintiffs claim, among other things, that such amendments breached NuScale LLC’s 5 th Amended and Restated Operating Agreement and required the consent of holders of common units in NuScale LLC voting as a separate class. NuScale LLC filed a motion to dismiss the complaint on November 21, 2022. Plaintiffs filed a response on January 17, 2023, and NuScale LLC filed a reply on February 14, 2023. While no assurance can be given as to the ultimate outcome of this matter, the Company does not believe it is probable that a loss will be incurred and the Company has not recorded any liability as a result of these actions. In conjunction with DOE Office of Nuclear Energy Award DE-NE0008935 with Utah Associated Municipal Power Systems’ (“UAMPS”) wholly owned subsidiary, CFPP LLC, the Company entered into a DCRA, pursuant to which it is developing the NRC license application and performing other site licensing and development activities. Under the DCRA, the Company may be obligated to refund to UAMPS a percentage of its net development costs up to a specified cap, which varies based on the stage of project development, if certain performance criteria are not met. As of March 7, 2023, when the Company entered into Amendment 3 of the DCRA and the Long Lead Material Reimbursement Agreement with CFPP LLC, the maximum reimbursement based on the current stage of project development was $81,000. As of March 31, 2023 the net development costs incurred by UAMPS totaled $29,805. Under the DCRA, the Company is required to have credit support to fund the amount of its potential reimbursement of these net development costs. A stipulation of obtaining the letter of credit is for the Company to segregate funds from the operating bank accounts as collateral for the letter of credit. This account is identified as restricted cash in the amount of $34,182, on the accompanying consolidated balance sheet and acts as collateral for the $33,500 letter of credit outstanding at March 31, 2023. On April 17, 2023, this letter of credit was increased to $44,200. In December 2022, NuScale and Fluor provided CFPP LLC with the results of an economic competitiveness test (“ECT”) comparing the calculated levelized cost of electricity (“LCOE”) for the Carbon Free Power Project (the “CFPP”) with the price target of $58.00/MWh as provided for under the amended DCRA. The LCOE exceeded the price target, meaning there was an ECT Failure. As a result of the ECT Failure UAMPS Members participating in the CFPP were given the opportunity to exit the Project. CFPP LLC had until March 1, 2023 to deliver notice that it intended to terminate its participation in the Project. If CFPP LLC had issued notice that it intended to terminate its participation in the Project by March 1, 2023, the Company could have been liable to pay CFPP LLC approximately $29,805 and the Company would then have had the option to take over the Project assets and continue to develop the CFPP. However, on March 1, 2023, UAMPS notified NuScale confirming that sufficient Project Participants have opted to continue with CFPP development notwithstanding the ECT failure. The next ECT is scheduled to be run in conjunction with the submission of the Class 2 Project Cost Estimate. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 3 Months Ended |
Mar. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | Basis of Presentation The Company’s unaudited condensed consolidated financial statements and related notes do not include notes and certain financial information normally presented annually under GAAP, and therefore should be read in conjunction with our 2022 Annual Report on Form 10-K. Accounting measures at interim dates inherently involve greater reliance on estimates than at year-end. Although such estimates are based on management’s most recent assessment of the underlying facts and circumstances utilizing the most current information available, our reported results of operations may not necessarily be indicative of results that we expect for the full year. These financial statements are unaudited. In management’s opinion, they contain all adjustments of a normal recurring nature which are necessary to present fairly our financial position and our operating results as of and for the interim periods presented. |
Principles of Consolidation | Principles of ConsolidationAs part of the Transaction, NuScale Corp has been determined to be the primary beneficiary of NuScale Power, LLC (“NuScale LLC”), a variable interest entity (“VIE”). As the sole managing member of NuScale LLC, NuScale Corp has both the power to direct the activities, and direct ownership to share in the revenues and expenses of NuScale LLC. As such, all the activity of NuScale LLC has been consolidated in the accompanying condensed consolidated financial statements. All assets and liabilities included in the balance sheet are that of NuScale LLC, other than the NuScale Corp Warrants and certain prepaid insurance. All significant intercompany transactions have been eliminated upon consolidation. |
Cash, Cash Equivalents and Restricted Cash | Cash, Cash Equivalents and Restricted Cash Cash equivalents represent short-term, highly liquid investments, which are readily convertible to cash and have maturities of three months or less at time of purchase. Cash equivalents with an initial maturity of between three and twelve months at time of purchase are presented as short-term investments on the accompanying condensed consolidated balance sheet. Cash equivalents and short-term investments consist of certificates of deposit. These certificates of deposit are classified as held-to-maturity, and the estimated fair value of the investment approximates its amortized cost. |
Warrant Liability | Warrant Liability The Company accounts for the Warrants in accordance with the guidance contained in Accounting Standards Codification (“ASC”) 815, “Derivatives and Hedging”, under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjusts the warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s condensed consolidated statements of operations. The fair value of the Public and Private Placement Warrants has been estimated using the Public Warrants’ quoted market price. See note 4 for further discussion of the terms of the Warrants and note 5 for further discussion of the methodology used to determine the value of the Warrants. |
Income Taxes | Income Taxes NuScale Corp accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that the deferred tax assets will be realized. Deferred tax assets and liabilities are calculated by applying existing tax laws and the rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the year of the enacted rate change. The Company accounts for uncertainty in income taxes using a recognition and measurement threshold for tax positions taken or expected to be taken in a tax return, which are subject to examination by federal and state taxing authorities. The tax benefit from an uncertain tax position is recognized when it is more likely than not that the position will be sustained upon examination by taxing authorities based on technical merits of the position. The amount of the tax benefit recognized is the largest amount of the benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. The effective tax rate and the tax basis of assets and liabilities reflect management’s estimates of the ultimate outcome of various tax uncertainties. Once identified, the Company will recognize penalties and interest related to uncertain tax positions within the provision (benefit) for income taxes line in the accompanying consolidated statements of operations. NuScale LLC is a limited liability company treated as a partnership for U.S. federal income tax purposes that is not subject to U.S. federal income tax. As such, its net taxable income or loss and any related tax credits are allocated to its members. |
Fair Value Measurement | The Company measures certain financial assets and liabilities at fair value. Fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the Company uses a three-level hierarchy, which prioritizes fair value measurements based on the types of inputs used for the various valuation techniques (market approach, income approach and cost approach). The levels of hierarchy are described below: Level 1 Quoted prices in active markets for identical instruments; Level 2 Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and Level 3 Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability. Financial assets and liabilities are classified in their entirety based on the most stringent level of input that is significant to the fair value measurement. The carrying amount of certain financial instruments, including deposits, accounts payable, accrued expenses and convertible notes payable approximates fair value due to their short maturities. Our Warrants are accounted for as liabilities pursuant to ASC 815-40 and are measured at fair value as of each reporting period. Changes in fair value of the Warrants are recorded in the consolidated statements of operations each period. Due to the similarity of the features of the Public and Private Warrants, management has concluded that the |
Noncontrolling Interests and _2
Noncontrolling Interests and Loss Per Share (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Noncontrolling Interest And Earnings Per Share [Abstract] | |
Schedule of Non-Controlling Interests | The following table summarizes the economic interests of NuScale Corp between the holders of Class A common stock and indirect economic interests held by NuScale LLC Class B unitholders as of and for the three months ended March 31, 2023: Noncontrolling Interest As of and for the three months ended March 31, 2023 NuScale Corp Class A common stock Beginning of period 69,353,019 Conversion of combined interests into Class A common stock — Exercise of options and warrants and vested RSUs 708,036 End of period 70,061,055 NuScale LLC Class B Units (NCI) Beginning of period 157,090,820 Conversion of combined interests into Class A common stock — End of period 157,090,820 Total Beginning of period 226,443,839 Conversion of combined interests into Class A common stock — Exercise of options and warrants and vested RSUs 708,036 End of period 227,151,875 Ownership Percentage NuScale Corp Class A common stock Beginning of period 30.6 % End of period 30.8 % NuScale LLC Class B Units (NCI) Beginning of period 69.4 % End of period 69.2 % |
Schedule of Earnings Per Share, Basic and Diluted | The following table sets forth the computation of basic and diluted net loss per share of Class A common stock and represents the three months ended March 31, 2023, the period where the Company had Class A and Class B common stock outstanding. Class B common stock represents a right to cast one vote per share at the NuScale Corp level, and carry no economic rights, including rights to dividends or distributions upon liquidation, and as a result, is not considered a participating security for basic and diluted loss per share. As such, basic and diluted loss per share of Class B common stock has not been presented. Three Months Ended March 31, 2023 Net loss attributable to Class A common stockholders $ (10,962) Weighted-average shares for basic and diluted loss per share 69,684,268 Basic and Diluted loss per share of Class A common stock $ (0.16) Anti-dilutive securities excluded from shares outstanding: Class B common shares 157,090,820 Stock options 11,447,940 Warrants 18,458,701 Time-based RSUs 3,910,760 Total 190,908,221 |
Fair Value Measurement (Tables)
Fair Value Measurement (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Schedule of Fair Value, Liabilities Measured on Recurring Basis | The following table represents the Company’s financial liabilities measured at fair value on a recurring basis as of March 31, 2023: (in thousands) Level 1 Level 2 Level 3 Total Warrant Liabilities: Public Warrants $ 15,772 $ — $ — $ 15,772 Private Placement Warrants — 14,685 — 14,685 Total Warrant Liabilities as of March 31, 2023 $ 15,772 $ 14,685 $ — $ 30,457 |
Property, Plant and Equipment (
Property, Plant and Equipment (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Property, Plant and Equipment [Abstract] | |
Schedule of Property, Plant and Equipment | Property, plant and equipment consisted of the following: March 31, December 31, (in thousands) 2023 2022 Furniture and fixtures $ 145 $ 173 Office and computer equipment 7,475 7,393 Software 13,918 13,864 Test equipment 347 347 Leasehold improvements 2,281 2,312 24,166 24,089 Less: Accumulated depreciation (19,947) (19,431) Add: Assets under development 287 112 Net property, plant and equipment $ 4,506 $ 4,770 |
Equity-Based Compensation (Tabl
Equity-Based Compensation (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Share-Based Payment Arrangement [Abstract] | |
Schedule of Share-based Payment Arrangement, Option, Activity | The following table summarizes the activity of the Company’s common stock options as of and for the three months ended March 31, 2023: Share Options Number of Weighted Average Outstanding at December 31, 2022 12,224,783 $ 4.09 Granted — — Exercised (693,734) 2.30 Forfeited (80,674) 6.43 Expired (2,435) 5.54 Outstanding at March 31, 2023 11,447,940 4.18 Exercisable at March 31, 2023 10,379,278 3.90 |
Schedule of Share-Based Payment Arrangement, Restricted Stock Unit, Activity | The following table summarizes the activity of the Company’s time-based RSUs as of and for the three months ended March 31, 2023: Number of RSUs Weighted Average Time-based RSUs Grant-Date Fair Value Outstanding at December 31, 2022 2,140,651 $ 10.71 Granted 1,835,016 10.35 Vested (14,300) 10.20 Forfeited/Expired (50,607) 11.12 Outstanding at March 31, 2023 3,910,760 $ 10.54 |
Nature of Business - Narrative
Nature of Business - Narrative (Details) | Mar. 31, 2023 MW |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Number of megawatts (mw) | 77 |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2023 | Mar. 31, 2022 | Dec. 31, 2022 | |
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Collaborative arrangement, cost share | $ 115 | ||
Restricted cash | 34,182 | $ 26,532 | |
Nuscale SMR FOAK Nuclear Demonstration Readiness Project Completion | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Collaborative arrangement, cost share | 12,354 | $ 20,462 | |
United State Trade and Development Agency | Government | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Collaborative arrangement, cost share | 2,415 | $ 115 | |
Carbon Free Power Project Award | Government | |||
Accounts, Notes, Loans and Financing Receivable [Line Items] | |||
Collaborative arrangement, government cost share | $ 2,939 |
Noncontrolling Interests and _3
Noncontrolling Interests and Loss Per Share - Schedule of Non-Controlling Interests (Details) | 3 Months Ended |
Mar. 31, 2023 shares | |
Noncontrolling Interest [Roll Forward] | |
Beginning of period (in shares) | 226,443,839 |
Conversion of combined interests into Class A common stock (in shares) | 0 |
Exercise of options and warrants and vested RSUs (in shares) | 708,036 |
End of period (in shares) | 227,151,875 |
Class A | |
Noncontrolling Interest [Roll Forward] | |
Beginning of period (in shares) | 69,353,019 |
Conversion of combined interests into Class A common stock (in shares) | 0 |
Exercise of options and warrants and vested RSUs (in shares) | 708,036 |
Class A | NuScale Corp | |
Controlling and Non Controlling Interest [Roll Forward] | |
Beginning of period | 30.60% |
End of period | 30.80% |
Class B | |
Noncontrolling Interest [Roll Forward] | |
Beginning of period (in shares) | 157,090,820 |
Conversion of combined interests into Class A common stock (in shares) | 0 |
Class B | NuScale LLC | |
Controlling and Non Controlling Interest [Roll Forward] | |
Beginning of period | 69.40% |
End of period | 69.20% |
Noncontrolling Interests and _4
Noncontrolling Interests and Loss Per Share - Narrative (Details) | Mar. 31, 2023 |
Noncontrolling Interest And Earnings Per Share [Abstract] | |
Common stock, votes per share | 1 |
Noncontrolling Interests and _5
Noncontrolling Interests and Loss Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Noncontrolling Interest And Earnings Per Share [Abstract] | ||
Net loss attributable to Class A common stockholders, basic | $ (10,962) | |
Net loss attributable to Class A common stockholders, diluted | $ (10,962) | |
Weighted-average shares for basic loss per share (in shares) | 69,684,268 | 0 |
Weighted-average shares for diluted loss per share (in shares) | 69,684,268 | 0 |
Basic loss per share of Class A common stock (in usd per share) | $ (0.16) | $ 0 |
Diluted loss per share of Class A common stock (in usd per share) | $ (0.16) | $ 0 |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Total | 190,908,221 | |
Class B common shares | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Total | 157,090,820 | |
Stock options | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Total | 11,447,940 | |
Warrants | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Total | 18,458,701 | |
Time-based RSUs | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Total | 3,910,760 |
Warrant Liabilities - Narrative
Warrant Liabilities - Narrative (Details) | 3 Months Ended |
Mar. 31, 2023 d $ / shares shares | |
Derivative [Line Items] | |
Warrants and rights outstanding, term (in years) | 5 years |
Period after transaction when private placement warrants become identical to public warrants | 30 days |
Warrant Redemption Scenario One | |
Derivative [Line Items] | |
Stock price trigger (in usd per share) | $ / shares | $ 18 |
Redemption price (in usd per share) | $ / shares | $ 0.01 |
Prior written notice period for redemption (in days) | 30 days |
Threshold trading days | 20 |
Threshold ending trading days | 3 |
Threshold consecutive trading day period | 30 |
Warrant Redemption Scenario Two | |
Derivative [Line Items] | |
Stock price trigger (in usd per share) | $ / shares | $ 10 |
Redemption price (in usd per share) | $ / shares | $ 0.10 |
Prior written notice period for redemption (in days) | 30 days |
Threshold trading days | 20 |
Threshold consecutive trading day period | 30 |
Public Warrants | |
Derivative [Line Items] | |
Class of warrant outstanding | shares | 9,558,701 |
Private Placement Warrants | |
Derivative [Line Items] | |
Class of warrant outstanding | shares | 8,900,000 |
Fair Value Measurement (Details
Fair Value Measurement (Details) - Fair Value, Recurring $ in Thousands | Mar. 31, 2023 USD ($) |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Warrant liabilities | $ 30,457 |
Public Warrants | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Warrant liabilities | 15,772 |
Private Placement Warrants | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Warrant liabilities | 14,685 |
Level 1 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Warrant liabilities | 15,772 |
Level 1 | Public Warrants | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Warrant liabilities | 15,772 |
Level 1 | Private Placement Warrants | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Warrant liabilities | 0 |
Level 2 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Warrant liabilities | 14,685 |
Level 2 | Public Warrants | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Warrant liabilities | 0 |
Level 2 | Private Placement Warrants | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Warrant liabilities | 14,685 |
Level 3 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Warrant liabilities | 0 |
Level 3 | Public Warrants | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Warrant liabilities | 0 |
Level 3 | Private Placement Warrants | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
Warrant liabilities | $ 0 |
Accounts and Other Receivables
Accounts and Other Receivables - Narrative (Details) $ in Thousands | Mar. 31, 2023 USD ($) |
Receivables [Abstract] | |
Interest receivable | $ 329 |
Property, Plant and Equipment_2
Property, Plant and Equipment (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Property, Plant and Equipment [Line Items] | ||
Less: Accumulated depreciation | $ (19,947) | $ (19,431) |
Net property, plant and equipment | 4,506 | 4,770 |
Depreciable Property, Plant And Equipment | ||
Property, Plant and Equipment [Line Items] | ||
Total property, plant and equipment gross | 24,166 | 24,089 |
Furniture and fixtures | ||
Property, Plant and Equipment [Line Items] | ||
Total property, plant and equipment gross | 145 | 173 |
Office and computer equipment | ||
Property, Plant and Equipment [Line Items] | ||
Total property, plant and equipment gross | 7,475 | 7,393 |
Software | ||
Property, Plant and Equipment [Line Items] | ||
Total property, plant and equipment gross | 13,918 | 13,864 |
Test equipment | ||
Property, Plant and Equipment [Line Items] | ||
Total property, plant and equipment gross | 347 | 347 |
Leasehold improvements | ||
Property, Plant and Equipment [Line Items] | ||
Total property, plant and equipment gross | 2,281 | 2,312 |
Add: Assets under development | ||
Property, Plant and Equipment [Line Items] | ||
Total property, plant and equipment gross | $ 287 | $ 112 |
Long-Term Contract Work In Pr_2
Long-Term Contract Work In Process (Details) - USD ($) $ in Thousands | May 09, 2023 | Mar. 31, 2023 | Dec. 31, 2022 |
Debt Instrument [Line Items] | |||
Long-term contract work in process | $ 16,018 | $ 0 | |
CFPP LLC | Long Lead Material Contract | |||
Debt Instrument [Line Items] | |||
Debt instrument, debt default, amount | 54,600 | ||
Long-term contract work in process | $ 14,200 | ||
CFPP LLC | Long Lead Material Contract | Subsequent Event | |||
Debt Instrument [Line Items] | |||
Long-term deferred revenue liability | $ 22,275 |
Employee Benefits - Narrative (
Employee Benefits - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Defined Contribution Plan Disclosure [Line Items] | ||
Defined contribution plan expense | $ 751 | $ 672 |
Defined Contribution Plan, Tranche One | ||
Defined Contribution Plan Disclosure [Line Items] | ||
Defined contribution plan, employer matching contribution, percent of employees' gross pay | 3% | |
Defined contribution plan, employer matching contribution, percent of match | 100% | |
Defined Contribution Plan, Tranche Two | ||
Defined Contribution Plan Disclosure [Line Items] | ||
Defined contribution plan, employer matching contribution, percent of employees' gross pay | 2% | |
Defined contribution plan, employer matching contribution, percent of match | 50% |
Income Taxes - Narrative (Detai
Income Taxes - Narrative (Details) | 3 Months Ended | 11 Months Ended |
Mar. 31, 2023 | Mar. 31, 2023 | |
Income Tax Disclosure [Abstract] | ||
Effective income tax rate, percent | 0% | 0% |
Equity-Based Compensation - Nar
Equity-Based Compensation - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands | 1 Months Ended | 3 Months Ended | 12 Months Ended | ||
Feb. 28, 2022 | Apr. 30, 2013 | Mar. 31, 2023 | Mar. 31, 2022 | Dec. 31, 2022 | |
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||||
Increase in number of common stock percentage | 4% | ||||
Number of shares converted | 190,908,221 | ||||
Time-based RSUs | |||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||||
Number of shares converted | 3,910,760 | ||||
Share-Based Payment Arrangement, Option | |||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||||
Share based compensation expense | $ 3,637 | $ 1,021 | |||
Common Unit Appreciation Rights (UARs) | |||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||||
Increase to share pool (in shares) | 8,972,128 | ||||
Common Unit Appreciation Rights (UARs) | Chief Executive Officer | |||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||||
Share based compensation expense | $ 1,490 | ||||
Granted (in shares) | 1,000,000 | ||||
Strike price (in usd per share) | $ 0.11 | ||||
Share based compensation arrangement, accrued liability to settle award | $ 1,540 | ||||
Vesting percentage | 33.33% | ||||
Time-based RSUs | |||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||||
Shares approved (in shares) | 1,835,016 | ||||
Award requisite service period (in years) | 3 years | ||||
Time-based RSUs | 2022 Long-Term Incentive Plan | |||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||||
Vesting percentage | 33.33% | ||||
General and Administrative Expense | Share-Based Payment Arrangement, Option | |||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||||
Share based compensation expense | $ 1,493 | 444 | |||
Other Expense | Share-Based Payment Arrangement, Option | |||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||||
Share based compensation expense | $ 2,144 | $ 577 |
Equity-Based Compensation - Sch
Equity-Based Compensation - Schedule of Share-based Payment Arrangement, Option, Activity (Details) | 3 Months Ended |
Mar. 31, 2023 $ / shares shares | |
Number of Shares | |
Outstanding at December 31, 2022 (in shares) | shares | 12,224,783 |
Granted (in shares) | shares | 0 |
Exercised (in shares) | shares | (693,734) |
Forfeited (in shares) | shares | (80,674) |
Expired (in shares) | shares | (2,435) |
Outstanding at March 31, 2023 (in shares) | shares | 11,447,940 |
Exercisable at March 31, 2023 (in shares) | shares | 10,379,278 |
Weighted Average Exercise Price | |
Outstanding at December 31, 2022 (in usd per share) | $ / shares | $ 4.09 |
Granted (in usd per share) | $ / shares | 0 |
Exercised (in usd per share) | $ / shares | 2.30 |
Forfeited (in usd per share) | $ / shares | 6.43 |
Expired (in usd per share) | $ / shares | 5.54 |
Outstanding at March 31, 2023 (in usd per share) | $ / shares | 4.18 |
Exercisable at March 31, 2023 (in usd per share) | $ / shares | $ 3.90 |
Equity-Based Compensation - S_2
Equity-Based Compensation - Schedule of Share-Based Payment Arrangement, Restricted Stock Unit, Activity (Details) - Time-based RSUs | 3 Months Ended |
Mar. 31, 2023 $ / shares shares | |
Number of RSUs | |
Number of shares, beginning balance (in shares) | shares | 2,140,651 |
Granted (shares) | shares | 1,835,016 |
Vested (in shares) | shares | (14,300) |
Forfeited/Expired (in shares) | shares | (50,607) |
Number of shares, ending balance (in shares) | shares | 3,910,760 |
Weighted Average Grant Date Fair Value | |
Beginning balance (in usd per share) | $ / shares | $ 10.71 |
Granted (in usd per share) | $ / shares | 10.35 |
Vested (in usd per share) | $ / shares | 10.20 |
Forfeited/Expired (in usd per share) | $ / shares | 11.12 |
Ending balance (in usd per share) | $ / shares | $ 10.54 |
Related Party Transactions - Na
Related Party Transactions - Narrative (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2023 | Mar. 31, 2022 | Dec. 31, 2022 | |
Related Party Transaction [Line Items] | |||
Related party expenses | $ 8,726 | $ 3,601 | |
Accounts payable, related parties | 9,162 | $ 7,694 | |
Revenue from related parties | 4,014 | $ 1,561 | |
Fluor | |||
Related Party Transaction [Line Items] | |||
Accounts receivable, related parties | $ 6,101 | $ 1,508 | |
Percentage of revenue earned | 72.90% |
Commitment and Contingencies (D
Commitment and Contingencies (Details) $ / shares in Units, $ in Thousands | 3 Months Ended | ||
Apr. 17, 2023 USD ($) | Sep. 19, 2022 plaintiff | Mar. 31, 2023 USD ($) $ / shares | |
Loss Contingencies [Line Items] | |||
Number of plaintiffs | plaintiff | 13 | ||
Development Cost Reimbursement Agreement | |||
Loss Contingencies [Line Items] | |||
Maximum reimbursement based on the current stage of project development | $ 29,805 | ||
Collaborative arrangements, restricted cash, letter of credit, deposit in demand amount | 34,182 | ||
Collaborative arrangements, restricted cash, letter of credit, collateral amount | $ 33,500 | ||
Collaborative arrangements, comparing target price | $ / shares | $ 58 | ||
Development Cost Reimbursement Agreement | Subsequent Event | |||
Loss Contingencies [Line Items] | |||
Increase in letter of credit | $ 44,200 | ||
UAMPS Member | Development Cost Reimbursement Agreement | |||
Loss Contingencies [Line Items] | |||
Maximum reimbursement based on the current stage of project development | $ 81 |